Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

The 7 Best Cannabis Stocks to Buy for Long-Term Growth

By Muslim Farooque, InvestorPlace Contributor
These best marijuana stocks offer remarkable long-term prospects with U.S. federal legalization looming

Why Is Codiak BioSciences (CDAK) Stock Down 52% Today?

By William White, InvestorPlace Writer
Codiak BioSciences (CDAK) stock is falling hard on Monday after the company announced plans for an asset sale through a Chapter 11 bankruptcy.

Why Is Unity Biotechnology (UBX) Stock Down 52% Today?

By William White, InvestorPlace Writer
Unity Biotechnology (UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325.

3 Low P/E Stocks That Are Bound to Rebound This Year

By Faisal Humayun, InvestorPlace Contributor
These are the low P/E stocks to buy at current levels for a sharp reversal rally in the coming quarters.

Why Is NuCana (NCNA) Stock Down 36% Today?

By William White, InvestorPlace Writer
NuCana (NCNA) stock is sliding lower on Monday after the company got an unfortunate patent update from the TBA of the EPO.

Why Is Coeptis Therapeutics (COEP) Stock Up 14% Today?

By William White, InvestorPlace Writer
Coeptis Therapeutics (COEP) stock is climbing higher alongside heavy trading on Monday despite a lack of news from the drug company.

3 Tech Stocks to Buy for the Fourth Industrial Revolution

By Larry Ramer, InvestorPlace Contributor
These companies all utilize multiple technologies that are part of the Fourth Industrial Revolution, making them great tech stocks to buy.

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket

By Ian Cooper, InvestorPlace Contributor
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.

Why Is Allarity Therapeutics (ALLR) Stock Down 23% Today?

By William White, InvestorPlace Writer
Allarity Therapeutics (ALLR) stock is sliding lower on Friday after announcing a reverse stock split happening later today.

5 Penny Stocks to Buy for 5X Returns

By Faisal Humayun, InvestorPlace Contributor
These are the undervalued penny stocks to buy that have multibagger returns potential in the next three years.

3 Nasdaq Stocks Facing Regulatory Hot Water in 2023

By Larry Ramer, InvestorPlace Contributor
Investors should certainly avoid these three Nasdaq stocks in trouble, and shorting them could turn out to be very profitable.

Why Is Dermata Therapeutics (DRMA) Stock Up 23% Today?

By William White, InvestorPlace Writer
Dermata Therapeutics (DRMA) stock is taking off on Friday despite a lack of news from the clinical-stage biotechnology company.

7 Biotech Stocks Sitting in the Sweet Spot

By Louis Navellier and the InvestorPlace Research Staff
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable.

3 Stocks That Won’t Survive a Major Market Crash

By Chris MacDonald, InvestorPlace Contributor
These three stocks appear to be particularly exposed to a potential market crash, and should be on investors' sell lists right now.

REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data

By William White, InvestorPlace Writer
Regeneron Pharmaceuticals (REGN) stock is on the rise Thursday after the company released its latest clinical trial data on Dupixent.

ZURA Stock Alert: Zura Bio SPAC Merger Rally Ends

By William White, InvestorPlace Writer
Zura Bio (ZURA) stock is on the move Thursday following the clinical-stage biotechnology company's public debut earlier this week.

7 Cannabis Stocks That Can Make You a Millionaire as Legalization Spreads

By Ian Cooper, InvestorPlace Contributor
Cannabis stocks could see higher highs with several key catalysts, creating a potential $100 billion opportunity.

Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?

By William White, InvestorPlace Writer
Cidara Therapeutics (CDTX) stock is falling on Thursday despite the immunotherapy company getting positive news from the FDA.

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 35% Today?

By William White, InvestorPlace Writer
ZyVersa Therapeutics (ZVSA) stock is taking off on Thursday morning without any recent news from the biopharmaceutical company.
Load More Articles